Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Treatment of Irritability in Huntington's Disease.

van Duijn E.

Curr Treat Options Neurol. 2010 Sep;12(5):424-33. doi: 10.1007/s11940-010-0088-3. Epub 2010 Jul 10.

2.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
4.

An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease.

Groves M, van Duijn E, Anderson K, Craufurd D, Edmondson MC, Goodman N, van Kammen DP, Goodman L.

PLoS Curr. 2011 Aug 30;3:RRN1259.

5.

[Alpha-interferon and mental disorders].

Debien C, De Chouly De Lenclave MB, Foutrein P, Bailly D.

Encephale. 2001 Jul-Aug;27(4):308-17. Review. French.

PMID:
11686052
6.

[Guidelines for the prescription of mood stabilizers for adolescents: A literature review].

Munch G, Godart N.

Encephale. 2016 Nov 18. pii: S0013-7006(16)30209-3. doi: 10.1016/j.encep.2016.09.005. [Epub ahead of print] French.

PMID:
27871720
7.

The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.

Alexopoulos GS, Katz IR, Reynolds CF 3rd, Carpenter D, Docherty JP; Expert Consensus Panel for Pharmacotherapy of Depressive Disorders in Older Patients.

Postgrad Med. 2001 Oct;Spec No Pharmacotherapy:1-86.

PMID:
17205639
8.

Pharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder.

Donnelly CL.

Child Adolesc Psychiatr Clin N Am. 2003 Apr;12(2):251-69. Review.

PMID:
12725011
9.

Psychopharmacologic treatment of pathologic aggression.

Fava M.

Psychiatr Clin North Am. 1997 Jun;20(2):427-51. Review.

PMID:
9196923
10.

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

Kane JM, Leucht S, Carpenter D, Docherty JP; Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.

J Clin Psychiatry. 2003;64 Suppl 12:5-19.

11.

A clinical approach to the pharmacotherapy of aggression in children and adolescents.

Connor DF, Steingard RJ.

Ann N Y Acad Sci. 1996 Sep 20;794:290-307. Review.

PMID:
8853610
12.

Sertraline in the treatment of severe aggressiveness in Huntington's disease.

Ranen NG, Lipsey JR, Treisman G, Ross CA.

J Neuropsychiatry Clin Neurosci. 1996 Summer;8(3):338-40.

PMID:
8854307
13.
14.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
15.

The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.

Posey DJ, McDougle CJ.

Harv Rev Psychiatry. 2000 Jul-Aug;8(2):45-63. Review.

PMID:
10902094
16.

Drugs for behavior disorders after traumatic brain injury: Systematic review and expert consensus leading to French recommendations for good practice.

Plantier D, Luauté J; SOFMER group.

Ann Phys Rehabil Med. 2016 Feb;59(1):42-57. doi: 10.1016/j.rehab.2015.10.003. Epub 2016 Jan 18. Review.

17.

[Psychiatric and psychological aspects of premenstrual syndrome].

Limosin F, Ades J.

Encephale. 2001 Nov-Dec;27(6):501-8. Review. French.

PMID:
11865558
18.

Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).

van Duijn E, Craufurd D, Hubers AA, Giltay EJ, Bonelli R, Rickards H, Anderson KE, van Walsem MR, van der Mast RC, Orth M, Landwehrmeyer GB; European Huntington's Disease Network Behavioural Phenotype Working Group.

J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1411-8. doi: 10.1136/jnnp-2013-307343. Epub 2014 May 14.

PMID:
24828898
19.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
20.

Co-occurring depressive symptoms in the older patient with schizophrenia.

Kasckow JW, Zisook S.

Drugs Aging. 2008;25(8):631-47. Review.

Supplemental Content

Support Center